Skip to content

Study on the detection efficiency of mNGS in pulmonary infection in patients with hematological diseases

Study on the detection efficiency of mNGS in pulmonary infection in patients with hematological diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052442
Enrollment
Unknown
Registered
2021-10-26
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological diseases complicated with pulmonary infection

Interventions

Sponsors

Hematology Hospital of Chiese Academy of Medical Sciences(Institute of Hematology Chinese Academy of Medical Sciences)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age: >=18 years old; 2. Underlying diseases: (1) Patients with acute leukemia/myelodysplastic syndrome/aplastic anemia complicated with neutropenia, or expected to have agranulocytosis for more than 10 days; (2) Continuous immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies; 3. Lung CT showed atelectasis; lung nodules, consolidation, ground glass, cord or patch shadows; diffuse lung lesions were considered in patients with pulmonary infection.

Exclusion criteria

Exclusion criteria: 1. Inability to tolerate pulmonary bronchoscopy; 2. Not signing informed consent; 3. Patients with other inappropriate inclusion criteria.

Design outcomes

Primary

MeasureTime frame
sputum mNGS;Bronchial lavage fluid mNGS;

Secondary

MeasureTime frame
Gram staining and acid fast staining of sputum smears;Bronchial lavage smears were stained with gram and acid fast;Blood GM test;Bronchial lavage fluid GM test;Blood G test;Bronchial lavage fluid X-Pert;

Countries

China

Contacts

Public ContactJiang Erlie

Hematology Hospital of Chiese Academy of Medical Sciences(Institute of Hematology Chinese Academy of Medical Sciences)

jiangerlie@163.com+86 23909018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026